Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
James Finlay Limited, commonly known as Finlays, is a leading global B2B supplier of tea, coffee, and botanical extracts with a history dating back to 1750. In the life sciences and healthcare sectors, the company is a major provider of high-purity natural active ingredients, including pharmaceutical-grade caffeine and tea polyphenols. Finlays operates a vertically integrated supply chain, utilizing advanced extraction, purification, and spray-drying technologies to serve the pharmaceutical, nutraceutical, and functional beverage industries. The company focuses on sustainable sourcing and rigorous quality standards, providing standardized botanical derivatives used for their antioxidant and stimulant properties. Headquartered in the UK and owned by the Swire Group, Finlays continues to innovate in the extraction of bioactive compounds for global health and wellness markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on James Finlay Limited.